MASUI Sho

Therapeutic antibodies play a crucial role in addressing challenging diseases like tumors and chronic inflammatory diseases. Despite their significance, there exists a gap in knowledge regarding their pharmacokinetics. To enhance the effectiveness of antibody-based treatments, it is essential to gain a precise understanding and assessment of pharmacokinetics and its associated variables. Currently, my research focuses on investigating the pharmacokinetics of antibody drugs. The following studies are being conducted: Verification of the Clinical Utility of Therapeutic Drug Monitoring for Therapeutic antibodies Detection of Biotransformation and Assessment of its Impact on the Pharmacokinetics